NASDAQ
Insight Molecular Diagnostics Inc. (IMDX) has a current ratio of 1.27x as of Monday, May 25, 2026. This represents a 36.50% decrease compared to its 12-month average of 2.00x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.